P3 Health Partners

PIII

Market cap$2.96 B

Rank#1818

SEC filings387

P3 Health Partners trades as PIII and has a market capitalization of $2.96 B, making it the #1818 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.46B, down 2.8% from the prior year and net income of -$147.95M. This page tracks P3 Health Partners through 387 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$1.46BFY 2025

Net income (latest FY)-$147.95MFY 2025

Operating cash flow (latest FY)-$91.24MFY 2025

Total assets (latest FY)$656.64MFY 2024

Net margin-10.1%latest FY

Financial performance

Over the last 6 fiscal years P3 Health Partners's revenue grew from $145.48M to $1.46B, a compound annual growth rate of 46.9%. Net profit margin expanded from -28.8% to -10.1% over the same period - every figure below comes from the company's audited annual filings.

PIII annual revenueView details

Key statistics

Market cap: $2.96 B
EPS (diluted)FY 2025: $-45.26
Total equityas of 2025-06-30: $44.46M
Return on equity: -332.8%
Long-term debtas of 2026-03-31: $311.00M
Cash & equivalentsas of 2026-03-31: $25.50M
Current ratioas of 2026-03-31: 0.33

Latest filings

Filing	Type	Filed
Major company event	8-K	2026-05-26
Insider trade	4	2026-05-18
Major company event	8-K	2026-05-15
Quarterly report	10-Q	2026-05-14
Major company event	8-K	2026-05-14
Proxy materials	DEFA14A	2026-04-30
Proxy statement	DEF 14A	2026-04-30
Major company event	8-K	2026-04-28

Browse the full filing history (387 filings)

Recent press releases

P3 Health Partners Announces First Quarter 2026 Results2026-05-14
P3 Health Partners Announces First Quarter 2026 Results :: P3 Health Partners Inc. (PIII)
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call2026-04-16
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call :: P3 Health Partners Inc. (PIII)
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results2026-03-26
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results :: P3 Health Partners Inc. (PIII)
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call2026-03-13
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call :: P3 Health Partners Inc. (PIII)
P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO2025-12-02
P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

Similar companies

The largest companies sharing P3 Health Partners's SEC industry classification (services-health services).

LFSTLifeStance Health Group, Inc.$3.02 B PIII vs LFST

PRVAPrivia Health Group, Inc.$2.86 B PIII vs PRVA

WGSGeneDx Holdings Corp.$1.65 B PIII vs WGS

PNTGThe Pennant Group, Inc.$1.14 B PIII vs PNTG

INNVInnovAge Holding Corp.$1.02 B PIII vs INNV

Frequently asked questions

What is P3 Health Partners's market cap?

P3 Health Partners (PIII) has a market capitalization of $2.96 B as of 2026-05-29, ranking #1818 among US-listed companies.

How much revenue does P3 Health Partners make?

P3 Health Partners reported revenue of $1.46B for fiscal year 2025, a decrease of 2.8% year over year.

Is P3 Health Partners profitable?

In its latest fiscal year P3 Health Partners reported a net loss of $147.95M.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.